August 2021
Rehman publication, career development award advance CF research
August 20, 2021
July 2021
Boston Scientific acquires UI startup Farapulse
July 1, 2021
June 2021
PREP@Iowa offers research mentorship, career boost
June 2, 2021
May 2021
Cancer can't hide: advancing immunotherapy for melanoma
May 5, 2021 - Years of research have led to a greater understanding of how cancers hide from the immune system—and a promising immunotherapy treatment for melanoma.
April 2021
Polgreen receives $3.7M R01
April 14, 2021
March 2021
UI researchers examine potential for light, photosensitizing agents to treat soft tissue sarcoma
March 23, 2021
Phase I clinical trial group finds efficiencies, increases
March 15, 2021
February 2021
Carvour capstone project presentation headed for national stage
February 18, 2021
January 2021
Wei receives $2.3M R01
January 12, 2021 - Dr. Shunguang Wei has received his second R01 in less than 3 years.
Decreasing ceramides reduced obesity, insulin resistance in mice
January 4, 2021
December 2020
Boudreau Lab to improve mRNA measurement methods
December 14, 2020
November 2020
High-fat or ketogenic diet prevents heart failure in mouse study
November 24, 2020
October 2020
UI cystic fibrosis researchers receive $11.5 million NIH grant to develop new therapies
October 26, 2020
Welsh nominated for Sanford Lorraine Cross Award for pioneering cystic fibrosis research
October 16, 2020
September 2020
Boudreau earns third active R01
September 15, 2020 - In less than two years, Dr. Ryan Boudreau has received a third NIH grant bringing the total awarded to just over $4.9M. These funds allow Dr. Boudreau to further investigate mitroregulin, a protein he and his research team discovered, and its role in the genetic and molecular underpinnings of heart failure.
August 2020
Infectious Diseases T32 grant renewed for 6th time
August 28, 2020
July 2020
Scherer to study, promote vaccine uptake
July 31, 2020 - On two consecutive days, Dr. Aaron Scherer received a K01 from the National Institute on Aging and a U01 to partner with the Centers for Disease Control and Prevention. Both grants will enable him to better understand what motivates individuals to choose to take vaccines. In the setting of our current pandemic, his discoveries may prove critical in the coming months.
______________________________